Observational studyJapanese journal of clinical oncology2019

Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypes.

Eisuke Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.